About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 87 record(s)
Req # A-2021-10676
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PDCI Market Access over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10684
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and GlaxoSmithKline Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-10689
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Janssen over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
December 2021
Req # A-2021-00028
Implementing Arrangement (IA) on Surface Water Ocean Topography (SWOT) Phase C-F - 661Organization: Canadian Space Agency
November 2021
Req # A-2021-00031
Flight of the Measurements of Pollution in the Troposphere (MOPITT) Instrument on Earth Observing System (EOS AM)/Terra - 501Organization: Canadian Space Agency
November 2021
Req # A-2021-00034
Cooperation between NASA and the CSA on the Soil Moisture Active Passive (SMAP) Mission - 869Organization: Canadian Space Agency
November 2021
Req # A-2021-00043
Memorandum of Understanding between the NRC and the CSA to strengthen R&D collaboration in support of Canada's space program - 787Organization: Canadian Space Agency
November 2021
Req # A-2021-00047
BN0009624: Contracting with former public servantsOrganization: Canadian Space Agency
November 2021
Req # A-2021-19383
The daily calendar of meetings, calls and other taskings for Douglas Clark from May 1, 2021 to October 14, 2021.Organization: Patented Medicine Prices Review Board Canada
November 2021
Req # A-2021-10661
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Collective Oncology Network for Exchange, Cancer care Innovation, Treatment Access and Education over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
October 2021